BCRX vs. JAZZ
Compare and contrast key facts about BioCryst Pharmaceuticals, Inc. (BCRX) and Jazz Pharmaceuticals plc (JAZZ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BCRX or JAZZ.
Correlation
The correlation between BCRX and JAZZ is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BCRX vs. JAZZ - Performance Comparison
Loading data...
Key characteristics
BCRX:
1.18
JAZZ:
0.02
BCRX:
1.86
JAZZ:
0.24
BCRX:
1.22
JAZZ:
1.03
BCRX:
0.77
JAZZ:
0.00
BCRX:
5.33
JAZZ:
0.00
BCRX:
11.83%
JAZZ:
10.42%
BCRX:
55.74%
JAZZ:
34.50%
BCRX:
-97.74%
JAZZ:
-96.90%
BCRX:
-68.69%
JAZZ:
-43.13%
Fundamentals
BCRX:
$2.14B
JAZZ:
$6.72B
BCRX:
-$0.26
JAZZ:
$7.36
BCRX:
-0.28
JAZZ:
4.00
BCRX:
4.26
JAZZ:
1.65
BCRX:
56.59
JAZZ:
1.61
BCRX:
$503.49M
JAZZ:
$4.06B
BCRX:
$487.50M
JAZZ:
$3.45B
BCRX:
$40.77M
JAZZ:
$1.28B
Returns By Period
In the year-to-date period, BCRX achieves a 37.90% return, which is significantly higher than JAZZ's -10.86% return. Over the past 10 years, BCRX has outperformed JAZZ with an annualized return of -0.96%, while JAZZ has yielded a comparatively lower -4.98% annualized return.
BCRX
37.90%
40.14%
46.88%
65.13%
4.45%
13.07%
-0.96%
JAZZ
-10.86%
6.81%
-6.64%
0.72%
-9.59%
-0.82%
-4.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BCRX vs. JAZZ — Risk-Adjusted Performance Rank
BCRX
JAZZ
BCRX vs. JAZZ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BioCryst Pharmaceuticals, Inc. (BCRX) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BCRX vs. JAZZ - Dividend Comparison
Neither BCRX nor JAZZ has paid dividends to shareholders.
Drawdowns
BCRX vs. JAZZ - Drawdown Comparison
The maximum BCRX drawdown since its inception was -97.74%, roughly equal to the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for BCRX and JAZZ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BCRX vs. JAZZ - Volatility Comparison
BioCryst Pharmaceuticals, Inc. (BCRX) has a higher volatility of 24.20% compared to Jazz Pharmaceuticals plc (JAZZ) at 15.96%. This indicates that BCRX's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BCRX vs. JAZZ - Financials Comparison
This section allows you to compare key financial metrics between BioCryst Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BCRX vs. JAZZ - Profitability Comparison
BCRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported a gross profit of 140.97M and revenue of 145.53M. Therefore, the gross margin over that period was 96.9%.
JAZZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a gross profit of 793.22M and revenue of 897.84M. Therefore, the gross margin over that period was 88.4%.
BCRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported an operating income of 21.23M and revenue of 145.53M, resulting in an operating margin of 14.6%.
JAZZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported an operating income of -55.89M and revenue of 897.84M, resulting in an operating margin of -6.2%.
BCRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, BioCryst Pharmaceuticals, Inc. reported a net income of 32.00K and revenue of 145.53M, resulting in a net margin of 0.0%.
JAZZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Jazz Pharmaceuticals plc reported a net income of -92.54M and revenue of 897.84M, resulting in a net margin of -10.3%.